Surveyed Experts Indicate That The Combination Of Sutent And Taxol Has Advantages Over The Combination Of Avastin And Taxol

News — By on April 23, 2009 at 4:00 am

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed oncologists identify a therapy’s effect on overall survival as the attribute that most influences their prescribing decisions in metastatic triple-negative breast cancer.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback